1 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
2 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
3 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
4 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
5 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
6 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
7 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
8 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
9 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
10 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
11 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
12 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
13 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
14 Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
15 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
16 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
17 Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
18 BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
19 Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
20 Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
21 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
22 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
23 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
24 Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
25 Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
26 Division of Surgical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
27 Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
28 Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
29 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
30 Department of Genomics and Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
31 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
32 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
33 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
34 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
35 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
36 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
37 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
38 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
39 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
40 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.